MYNZ
Mainz Biomed NV
NASDAQ · Healthcare · Medical - Diagnostics & Research · DE
$3.59
+0.84%Margins
Gross margin
72.6%
EBITDA margin
-3005.0%
EBIT margin
-3005.0%
Net margin
-3018.3%
FCF margin
-2044.5%
-642.7%
Return on equity
-165.4%
Return on assets
-287.4%
Return on invested capital
0.05x
Asset turnover
-$11.0M
Cash from operations
$0.61
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025